Preclinical Biotechnology · Tel Aviv

Advanced therapies for the eye.

Aurora Pharmaceuticals is an Israeli biotechnology company developing advanced eye therapies.

Scroll 32.07° N   34.79° E
About

The eye is among the most delicate organs we have. It deserves medicines made with equal care.

Aurora was founded to develop a new generation of eye therapies. Our programs are at the preclinical stage, and we work alongside specialist research partners and clinical advisers. We share our work when it is ready, and discuss it in confidence with collaborators, investors and regulators.

Approach

Built on three commitments.

01 · Precision

Reach the cells that matter.
Nothing else.

We design for delivery to specific cell types, so that a treatment acts where it is needed and nowhere else.

Stage
Pre­clinical

Focused programs, advancing step by step.

02 · Safety first

Measured at every stage.

Imaging, tissue analysis and functional measurements.

03 · Rigor

Validated before it decides.

Base

Tel Aviv, Israel.

A small team working with specialist partners and advisers.

Company

A young company, built to last.

Legal name
Aurora Pharmaceuticals Ltd.
Headquarters
Tel-Aviv, Israel
Focus
Advanced eye therapies
Stage
Preclinical
Contact

Let's talk.

ran@aurora.icu

Ran Greenberg, CEO and Founder